Blog
Appointment of Head of Data Quality
Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...
The effect of self-diagnosis on patient outcomes
The internet is a wonderful place. You can find photos of places you want to visit, maps of your favourite mountain ranges, tutorials on how to bake the perfect birthday cake…the list goes on. In recent years, however, there has been a marked increase in the number of...
Pharma Business International Interview
Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry. The full article can be found here on page 10-11 Tell us about Talking Medicines?...
Tracking Covid vaccine progress through Medsmart®
In the race against new super spreading virus variants, the UK among other countries have implemented a fast streamed vaccine programme to protect the vulnerable as quickly as possible. Since the beginning of January, 17,916,181 people in the UK have been given their...
PatientMetRx a new AI driven social intelligence service launches today
Talking Medicines is the world’s first social intelligence company designed specifically for the pharmaceutical industry: PatientMetrx By structuring and translating the patient’s voice on social media into actionable intelligence, it focuses on assisting...
How the pandemic is impacting the way drugs are launched
Though we don’t yet know to what extent, it is clear the pandemic has had and will continue to have an impact on the pharmaceutical industry and how new drugs are launched. From a pharma perspective, not being able to communicate with healthcare professionals in their...
Softening of public attitude towards COVID-19 vaccines
In December Talking Medicines carried out two ‘pulse’ surveys of the UK public to gauge opinion towards COVID-19 vaccines and found that over the month, attitude had softened, with more people intending to take the vaccine once it becomes available to them. The...
Growing the Product Tech Team
We are so pleased to welcome four talented individuals to our team. Through their knowledge and experience, we look forward to accelerating our AI driven data insights product aligned to the needs of our commercial marketing pharmaceutical customers. Stewart McKee -...
Arthritis drugs could save the lives of critically ill COVID-19 patients
Using existing drugs in different, unintended therapy areas is no new proposition. Exploring other uses of medicines can result in the bypass of significant obstacles that exist in the traditional roadmap of a drug’s development. Reduced research time and lesser...